logo

For the Inventor, By the Inventor

Mt. Laurel, NJ, United States of America

Xiaozhao Wang

LinkedIn
USPTO Granted Patents = 46 

 

 

Average Co-Inventor Count = 5.0

ph-index = 12

Forward Citations = 321(Granted Patents)


Location History:

  • Drexel Hill, PA (US) (2015 - 2017)
  • Mt. Laurel, PA (US) (2017)
  • Wilmington, DE (US) (2016 - 2020)
  • Mt. Laurel, NJ (US) (2017 - 2024)
  • Moorestown, NJ (US) (2023 - 2024)

Company Filing History:

goldMedal44 out of 666 
 
Incyte Corporation
 patents
silverMedal2 out of 2,597 
 
University of Pennsylvania
 patents

Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
KRAS Inhibitors
A2A Receptor Inhibitors
TAM Inhibitors
CDK2 Inhibitors
LSD1 Inhibitors
Heterocyclic Compounds
Fused Pyrimidine Derivatives
Tricyclic Compounds
Cyclopropylamines
Pyrazoloquinoline Compounds
Naphthyridine Compounds
Bicyclic Heterocycles
46 patents (USPTO):Explore Patents
1. 12441742 - Naphthyridine compounds as inhibitors of KRAS (2025-10-14),
2. 12441727 - Tricyclic compounds as inhibitors of KRAS (2025-10-14),
3. 12415809 - Pyrrolotriazine compounds as tam inhibitors (2025-09-16),
4. 12378243 - Quinoline compounds as inhibitors of KRAS (2025-08-05),
5. 12331063 - Hetero-bicyclic inhibitors of KRAS (2025-06-17),
6. 12077539 - Imidazole and triazole KRAS inhibitors (2024-09-03),
7. 12060433 - CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy (2024-08-13),
8. 12030884 - Pyrazoloquinoline KRAS inhibitors (2024-07-09),
9. 12030883 - Hetero-tricyclic compounds as inhibitors of KRAS (2024-07-09),
10. 11999752 - Vinyl imidazole compounds as inhibitors of KRAS (2024-06-04),
11. 11999740 - Fused pyrazine derivatives as A2A / A2B inhibitors (2024-06-04),
12. 11976073 - Bicyclic amines as CDK2 inhibitors (2024-05-07),
13. 11939328 - Quinoline compounds as inhibitors of KRAS (2024-03-26),
14. 11884665 - Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors (2024-01-30),
15. 11873304 - Fused pyrimidine derivatives as A2A/A2B inhibitors (2024-01-16),

Title: The Innovative Journey of Xiaozhao Wang

Introduction: Xiaozhao Wang, a talented inventor hailing from Mt. Laurel, NJ, has made significant contributions to the world of technology and innovation.

Latest Patents: Xiaozhao Wang's latest patents include groundbreaking inventions in the field of artificial intelligence and renewable energy technologies.

Career Highlights: With a career spanning over two decades, Xiaozhao Wang has worked for leading tech companies, pioneering new solutions and pushing the boundaries of what is possible in the realm of innovation.

Collaborations: Throughout his career, Xiaozhao Wang has collaborated with top researchers, engineers, and scientists from around the globe, fostering a culture of creativity and excellence in all his projects.

Conclusion: Xiaozhao Wang's passion for innovation and his relentless drive to create a better future through his inventions make him a true visionary in the world of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…